Therapeutic Drug Monitoring of Risankizumab in Psoriasis Patients (BIOLOPTIM-RIS)

Clinical trial NCT05685940 · UNKNOWN

Trial details

NCT number: NCT05685940
Sponsor: University Hospital, Ghent
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Psoriasis Vulgaris

Start date: 2020-04-05
Primary completion: 2024-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.